# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
After Wednesday’s tech-led rebound amid the Federal Reserve’s rate decision, the stock market could be in for further gains. Th...
The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say followin...
Elevance Health reports Q2 revenues of $43.2 billion, slightly above consensus despite a 0.4% YoY decline driven by Medicaid me...
Investors expect Trump to ease Medicare Advantage regulations if he wins another term. This could lead to renewed merger talks ...